Matthew R. Conway

Mr. Conway’s experience includes representation of:

Mergers & Acquisitions

• Hellman & Friedman LLC and The Carlyle Group in their US$4.3 billion acquisition of Pharmaceutical Product Development, Inc., a contract research organization providing drug discovery, development, and lifecycle management services
• Silver Run Acquisition Corporation II in its US$3.8 billion initial business combination with Alta Mesa Holdings, LP and Kingfisher Midstream, LLC to become Alta Mesa Resources, Inc.
• Capital Safety, Inc., a personal protective equipment provider and portfolio company of KKR, in its US$2.5 billion sale to 3M Company
• An affiliate of Platinum Equity in its US$2.5 billion acquisition of Multi-Color Corporation, a provider of label solutions
• BWAY Corporation, a manufacturer of rigid metal and plastic containers used to package industrial, bulk food, and retail goods, in its US$2.4 billion sale to Stone Canyon Industries
• Press Ganey Holdings, Inc., a provider of patient experience measurement, performance analytics, and strategic advisory solutions, in its US$2.35 billion sale to EQT Partners
• ArcLight Capital, an infrastructure investment firm, in its US$2.17 billion acquisition of power plants from AEP
• Platinum Equity in its US$2.1 billion sale of BlueLine Rental, an equipment rental company for the construction, commercial, and industrial markets, to United Rentals
• Landmark Aviation, an operator of fixed base operations and provider of aviation maintenance, repair, and overhaul services, in its US$2 billion sale to BBA Aviation
• Veyance Technologies, a manufacturer and distributor of automotive components and portfolio company of The Carlyle Group, in its US$1.9 billion sale to Continental AG
• LogMeIn, a software company, in its US$1.8 billion merger with Citrix’s GoTo Business through a Reverse Morris Trust Transaction
• Riverstone Holdings in its US$1.5 billion acquisition of an 89% stake in Centennial Resource Production, a developer of oil and gas reserves in the Permian Basin
• Platinum Equity in its US$1.275 billion acquisition of Jostens, a provider of products, programs, and services for high schools and universities
• KKR in its US$1.1 billion acquisition of Capital Safety Group Limited, a UK-based manufacturer and designer of height safety and fall protection equipment
• Teladoc in its US$440 million acquisition of Best Doctors, a medical consultation company
• Assurex Health, Inc., a developer of genetic tests for the diagnosis and treatment of behavioral and chronic pain conditions, in its US$400 million sale to Myriad Genetics
• Teladoc in its US$352 million acquisition of Advance Medical, a leading global provider of telehealth services
• Platinum Equity in its acquisition of Livingston International, a Canada-based provider of customs brokerage, consulting, transportation, freight, and integrated logistics services
• Platinum Equity in its acquisition of WS Packaging Group, a provider of labels and packaging solutions for consumer packaged goods and pharmaceutical markets
• Platinum Equity in its Section 363 acquisition of Hunterstown generation facility and assets from GenOn, an affiliate of NRG Energy, through GenOn chapter 11 cases
• SK Capital Partners in its acquisition of SI Group, a developer and manufacturer of phenolic and alkylphenolic resins, alkylated phenols, and other chemical intermediates
• CityMaps, Inc., a social mapping service, in its sale to TripAdvisor
• Platinum Equity in its acquisition of Pacific Architects and Engineers (PAE), a US government contractor providing integrated defense services
• The Carlyle Group in its acquisition of Acosta Sales & Marketing, a full-service sales and marketing agency in the consumer goods industry
• Applause App Quality, a provider of mobile application quality tools and services, in its sale to Vista Equity Partners

Capital Markets

• Centennial Resource Development’s US$487.5 million block trade and US$505 million PIPE offering
• Allison Transmission, Inc. in its US$690 million IPO
• Teladoc, Inc. in its US$180 million IPO
• Seres Therapeutics, Inc. in its US$154 million IPO
• Aratana Therapeutics, Inc. in its US$142 million common stock offering
• Selecta Biosciences, Inc. in its US$70 million IPO